Changping Laboratory (CPL), founded in October 2020, is a new-type national R&D institution established by China, with its core campus located in Zhongguancun Life Science Park, Beijing.
As an important component of the national strategic science and technology framework, CPL is centered on life sciences and oriented toward major national strategic needs. It focuses on key areas including biomedical omics technologies, immunodiagnostics and therapeutics, advanced imaging and interventional technologies, and biological artificial intelligence.
CPL conducts cutting-edge upstream research across mechanistic studies, screening and diagnosis, and therapeutic intervention, to build a world-class innovation hub in life sciences.
Changping Laboratory (CPL) - International Postdoctoral Position Descriptions.pdf